SINGLE-CHAIN INFLIXIMAB ANTIBODY-TRANSFERRIN FUSION PROTEIN FOR ENHANCED EFFICACY AND INDICATIONS

ANTI-WT1 ANTIGEN-BINDING PROTEINS AND USES THEREOF

PHARMACEUTICAL COMPOSITION OF PVRIG/TIGIT BISPECIFIC ANTIBODY AND USE THEREOF

Compositions and Methods of Inhibiting MASP-1 and/or MASP-2 and/or MASP-3 for the Treatment of Various Diseases and Disorders

PLASMA KALLIKREIN BINDING PROTEINS AND USES THEREOF IN TREATING HEREDITARY ANGIOEDEMA

ANTI-KLK7 ANTIBODIES, ANTI-KLK5 ANTIBODIES, MULTISPECIFIC ANTI-KLK5/KLK7 ANTIBODIES, AND METHODS OF USE

MESOTHELIN BINDING PROTEINS AND USES THEREOF

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR ENHANCING CD8+ T CELL-DEPENDENT IMMUNE RESPONSES IN SUBJECTS SUFFERING FROM CANCER

ANTIBODIES SPECIFICALLY RECOGNIZING B- AND T-LYMPHOCYTE ATTENUATOR (BTLA) AND USES THEREOF

PROTEASE-ACTIVATABLE T CELL BISPECIFIC ANTIBODIES

ANTI-CD96 ANTIBODIES AND METHODS OF USE THEREOF

HUMANIZED CHIMERIC ANTIGEN RECEPTORS TARGETING THE B-CELL RECEPTOR OF CHRONIC LYMPHOCYTIC LEUKEMIA AND USES THEREOF

BISPECIFIC BINDING AGENTS BINDING TO CLDN18.2 AND CD3

ANTI-NOTCH3 ANTIBODY

ANTI-ADRENOMEDULIN NON-NEUTRALIZING ANTIBODY, METHOD FOR PREPARING SAME, AND USE THEREOF

ANTI-IL-1ß ANTIBODY AND PHARMACEUTICAL COMPOSITION THEREOF AND USE OF SAME

NOVEL ANTI-ANGPTL3 ANTIBODIES SUITABLE FOR HIGH CONCENTRATION COMPOSITIONS AND SUBCUTANEOUS ADMINISTRATION

ALBUMIN BINDING PROTEINS AND METHODS OF USE

SINGLE-CHAIN CRENEZUMAB ANTIBODY-TRANSFERRIN FUSION PROTEIN FOR ENHANCED EFFICACY AND INDICATIONS

ANTI-ETEC ADHESIN PROTEIN ANTIBODIES AND METHODS OF USE

Anti-Sars-COV-2 Antibodies and Uses Thereof

ANTIBODY DRUG CONJUGATES (ADC) THAT BIND TO 191P4D12 PROTEINS

BIFUNCTIONAL DEGRADERS FOR THE TREATMENT OF GRAVES DISEASE

ANTIGEN-BINDING MOLECULE FOR PROMOTING ELIMINATION OF ANTIGENS

PREDICTION OF AN INCREASE OF DPP3 IN A PATIENT WITH SEPTIC SHOCK

ANTIGEN-BINDING MOLECULE SPECIFICALLY BINDING TO GUCY2C AND CD3 AND PHARMACEUTICAL USE THEREOF

ANTI-TUMOR ANTIBODIES

METHODS OF TREATING CANCERS USING PD-1 AXIS BINDING ANTAGONISTS AND TAXANES

HER3 BINDING PROTEIN AND USE THEREOF

ANTIBODIES AND FRAGMENTS SPECIFIC FOR B-CELL MATURATION ANTIGEN AND USES THEREOF

ANTIBODIES THAT BIND TO HUMAN CCR8

MODIFIED ANTI-GALECTIN-9 ANTIBODY AND USES THEREOF

TRIVALENT AND TRISPECIFIC ANTIBODY CONSTRUCTS AND METHODS OF USE THEREOF

ANTI-CD100 ANTIBODY AND USE THEREOF

ANTI-ILT4 SINGLE-DOMAIN ANTIBODY AND USE THEREOF

ANTI-ROR1 ANTIBODY AND USE THEREOF

METHODS OF TREATING NEURODEGENERATIVE DISEASES

BROADLY NEUTRALIZING ANTIBODIES AGAINST RSV AND MPV PARAMYXOVIRUSES

ANTIBODY-DRUG CONJUGATES

MONOCLONAL ANTIBODIES SPECIFIC FOR FIBROBLAST GROWTH FACTOR RECEPTOR 4 (FGFR4) AND METHODS OF THEIR USE

ANTIBODY-DRUG CONJUGATES TARGETING CDH3 AND PREPARATION METHODS AND USES THEREOF

PEPTIDE LINKERS FOR CONSTRUCTION AND REDUCING AGGREGATION OF FUSION POLYPEPTIDES COMPRISING SUCH

CLAUDIN-6 BINDING MOIETIES AND USES THEREOF

COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER

Antigen Binders Specific For IL-23R And Uses Thereof

ADENO-ASSOCIATED VIRUS VECTORS AND METHODS OF THEIR USE FOR REDUCING THE RISK OF, TREATING, AND PREVENTING METASTASIS

ANTI-FUNGAL ANTIBODIES BINDING TO BETA GLUCAN

CD73 (NT5E) TARGETING POLYPEPTIDES

ANTIBODIES DIRECTED AGAINST INTERLEUKIN 36 RECEPTOR (IL-36R)

ANTIBODY MONO-OR MULTI-SPECIFIC TO EPHRIN TYPE-A RECEPTOR 10, CHIMERIC ANTIGEN RECEPTOR T-CELL EXPRESSING THE SAME AND USES THEREOF

ANTI-CTLA-4 ANTIBODY AND USE THEREOF

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

ANTI-CD200R1 ANTIBODIES AND METHODS OF USE THEREOF

ANTI-SIGLEC-9 ANTIBODIES AND USES THEREOF

ANTIBODY CAPABLE OF BINDING TO THYMIC STROMAL LYMPHOPOIETIN AND USE THEROF

ANTI-C-MET ANTIBODY DRUG CONJUGATES

RECOMBINANT POLYCLONAL PROTEINS TARGETING COVID-19 AND METHODS OF USE THEREOF

ANTIBODIES FOR CHELATED RADIONUCLIDES

ANTIBODY MATERIALS AND METHODS TARGETING MICROBIAL POLYSACCHARIDES

FORMULATIONS OF ANTI-INTERLEUKIN 1 RECEPTOR 1 ANTIBODIES

ANTI-IL1RAP ANTIBODIES AND METHODS OF USE THEREOF

PROTEASE-CLEAVABLE SUBSTRATES AND METHODS OF USE THEREOF

ANTIBODIES SPECIFICALLY RECOGNIZING PROGRAMMED CELL DEATH1 LIGAND 1 AND USES THEREOF

ANTIGEN BINDING CONSTRUCTS TO CD8

ANTI-ROR1 ANTIBODY, BISPECIFIC ANTIBODY COMPRISING SAME, AND USES THEREOF

PATHOGEN BINDING PROTEINS

ANTI-CEACAM5 ANTIBODY-DRUG CONJUGATE AND METHOD FOR PREPARATION AND USE THEREOF

HUMANIZED ANTIBODIES AGAINST NECTIN-4 AND DRUG CONJUGATES THEREOF

CHECKPOINT REGULATOR ANTAGONISTS

GPRC5D x CD28 Bispecific Antibodies and Methods of Use Thereof

DOSAGES OF IMMUNOCONJUGATES OF ANTIBODIES AND SN-38 FOR IMPROVED EFFICACY AND DECREASED TOXICITY

HUMANIZED SINGLE-DOMAIN ANTIBODIES BINDING TO EPITOPE TAGS

ANTI-MERTK ANTIBODIES AND THEIR METHODS OF USE

5T4-BINDING PROTEINS

ANTIBODIES, COMPOSITIONS, AND METHODS OF TREATMENT

BISPECIFIC ANTI-CD38-CD3 BINDERS

Bispecific Anti-BCMA x Anti-CD3 Antibodies and Uses Thereof

ANTI-4-1BB ANTIBODIES AND METHODS OF MAKING AND USING THEREOF

ANTI-INTERLEUKIN-11 RECEPTOR SUBUNIT ALPHA (IL-11RA) ANTIBODIES

Antigen Binding Molecules Targeting Interleukine-4 Receptor Subunit Alpha (IL-4Ra)

KLRB1 BINDING AGENTS AND METHODS OF USE THEREOF

CD16A Antibodies and Methods of Use

Anti-B7-H3 Antibody and Methods of Use Thereof

ANTI-NECTIN-4 ANTIBODY, AND ANTIBODY-DRUG CONJUGATE AND USE THEREOF

ANTI-LILRB2 ANTIBODIES AND USES THEREOF

COMPOSITIONS AND METHODS FOR BLOOD-BRAIN BARRIER DELIVERY

MONOCLONAL ANTIBODIES TO GROWTH AND DIFFERENTIATION FACTOR 15 (GDF-15), AND USES THEREOF FOR TREATING CANCER CACHEXIA AND CANCER

Antibodies Blocking DLL4-Mediated Notch Signalling

VEGF-BINDING MOLECULE AND PHARMACEUTICAL USE THEREOF

SIALIDASE-RESISTANT SACCHARIDE AND METHOD OF MAKING AND USING THE SAME

CAMPTOTHECIN DERIVATIVES THAT BIND TO DDX5 PROTEIN AND PRODRUGS THEREOF

CHIMERIC ANTIGEN RECEPTOR WITH INCREASED AFFINITY FOR MESOTHELIN AND USE THEREOF

COMPOSITIONS AND METHODS RELATED TO TUMOR ACTIVATED ANTIBODIES TARGETING PSMA AND EFFECTOR CELL ANTIGENS

NOVEL POLYPEPTIDES

ANTIBODIES AGAINST SIGNAL-REGULATORY PROTEIN ALPHA AND METHODS OF USE

MEDICAMENTS, USES AND METHODS

VARIANT NUCLEIC ACID LIBRARIES FOR MAST CELLS

Anti-SLAMF7 Antibodies And Therapeutics

METHODS OF ENHANCING EFFICACY OF IMMUNOCONJUGATES USING PAIRED HUMAN ANTIBODIES TARGETED AT NON-OVERLAPPING B-CELL EPITOPES ON THE SAME ANTIGEN

MULTISPECIFIC ANTIBODY AND PREPARATION METHOD AND USE THEREOF

ANTI-DENGUE VIRUS ANTIBODIES, POLYPEPTIDES CONTAINING VARIANT FC REGIONS, AND METHODS OF USE

ANTI-CHIKV ANTIBODIES AND USES THEREOF

CHIMERIC ANTIGEN RECEPTOR THERAPIES FOR TREATING CANCER WITH IL7Fc ARMORED CAR-T CELLS

BISPECIFIC ANTIGEN BINDING MOLECULES THAT BIND GDF8 AND ACTIVIN A AND USES THEREOF

MULTI-SPECIFIC MOLECULES AND MENTOD OF USE AND MAKING THEREOF

ANTI-FENTANYL ANTIBODIES

VARIANT FC REGIONS

VARIANT FC REGIONS

FGF21 MIMETIC ANTIBODIES AND USES THEREOF

FUSION PROTEINS WITH HALF LIFE EXTENDING DOMAINS

NOVEL TCTP-BINDING MOLECULE

ANTI-CD137 ANTIGEN-BINDING MOLECULE AND UTILIZATION THEREOF

ANTI-TSHR ANTIBODIES AND USES THEREOF

ANTI-CCR8 ANTIBODY AND USE THEREOFR

T CELL RECRUITING POLYPEPTIDES BASED ON CD3 REACTIVITY

CHIMERIC ANTIGEN RECEPTORS TARGETING GPRC5D

MULTI-SPECIFIC ANTIBODIES IN USES THEREOF IN AVIDITY RECEPTOR CROSSLINKING AND IMMUNE MODULATION

HUMANIZED AND AFFINITY-MATURED ANTI-CEACAM1 ANTIBODIES AND METHODS OF USE

ANTI-TNF-ALPHA ANTIBODIES AND COMPOSITIONS

BISPECIFIC BINDING MOLECULE

IMPROVED ANTI-ALBUMIN NANOBODIES AND THEIR USES

ANTIBODIES THAT BIND TO IGE-DEPENDENT HISTAMINE-RELEASING FACTOR AND USES THEREOF

ANTIBODY NEUTRALIZING HUMAN RESPIRATORY SYNCYTIAL VIRUS

ANTI-RESPIRATORY SYNCYTIAL VIRUS ANTIBODIES, AND METHODS OF THEIR GENERATION AND USE

ANTI-RESPIRATORY SYNCYTIAL VIRUS NEUTRALIZING ANTIBODY AND USE THEREOF

ANTI-FGFR3 ANTIBODY CONJUGATE AND MEDICAL USE THEREOF

COMMON LIGHT CHAIN MOUSE

FCRN/HSA BINDING MOLECULES AND METHODS OF USE

ANTIVENOM MONOCLONAL ANTIBODIES OF RUSSELLS VIPER AND USES THEREOF

MUC1 Antibodies and Methods of Use

ANTI-CD63 ANTIBODIES, CONJUGATES, AND USES THEREOF

NANOBODY AND NANOBODY-DRUG CONJUGATE TARGETING CD73, METHOD FOR PREPARING SAME, AND USE THEREOF

MUSCLE-TARGETING COMPLEXES AND USES THEREOF

COMPOSITIONS AND METHODS FOR TREATMENT OF THYROID EYE DISEASE

ANTI-EGFR/MET ANTIBODIES AND USES THEREOF

ANTI-PD-L1 ANTIBODIES, COMPOSITIONS AND ARTICLES OF MANUFACTURE

NANOBODY TARGETING CD150 PROTEIN AND USE THEREOF

Antibody Variable Domains And Antibodies Having Decreased Immunogenicity

ANTIBODIES TARGETING IL3

TARGETING GDF15-GFRAL PATHWAY

COMPLEMENT C3 ANTIGEN BINDING PROTEINS

POLYPEPTIDES EFFECTIVE AGAINST MULTIPLE CORONAVIRUSES

CROSS-SPECIFIC ANTIBODIES, USES AND METHODS FOR DISCOVERY THEREOF

ANTI-SARS-COV2 SPIKE (S) ANTIBODIES AND USES THEREOF

BISPECIFIC ANTIBODIES FOR HBV SURFACE ANTIGEN (HBSAG) AND CD3 AND USES THEREOF

ANTI-CEACAM5 ANTIBODIES, ANTIBODY-DRUG CONJUGATES AND METHODS OF USES THEREOF

EGFR AND C-MET BISPECIFIC BINDING AGENTS, CONJUGATES THEREOF AND METHODS OF USING THE SAME

PRNP RNAi AGENTS

BISPECIFIC ANTIBODY BINDING EGFR AND B7-H3

HUMANIZED ANTI-CD28 ANTIBODY AND BISPECIFIC ANTIBODY THEREOF WITH ANTI-CD40 ANTIBODY

MONOSPECIFIC AND MULTI-SPECIFIC ANTIBODIES

STRATEGY FOR HIGHLY SUPERIOR DR5 ACTIVATION INCLUDING IN TUMORS AND CANCERS

ANTI-4-1BB ANTIBODIES AND METHODS OF MAKING AND USING THEREOF

METHOD OF TREATING OR AMELIORATING METABOLIC DISORDERS USING BINDING PROTEINS FOR GASTRIC INHIBITORY PEPTIDE RECEPTOR (GIPR) IN COMBINATION WITH GLP-1 AGONISTS

Fc VARIANT WITH ENHANCED AFFINITY TO Fc RECEPTORS AND IMPROVED THERMAL STABILITY

HUMANIZED ANTI-HUMAN CD19 ANTIBODIES AND METHODS OF USE

Siglec Receptor Checkpoint Inhibitors and Method of Using Them to Inhibit Neoplastic Cell Growth

ANTIGEN-BINDING MOLECULE SPECIFICALLY BINDING TO DLL3 AND CD3, AND PHARMACEUTICAL USE THEREOF

Anti-mGluR2 Biparatopic Nanobodies and Uses Thereof

ANTI-CLDN18.2 ANTIBODY, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF

MODIFIED PRODUCT OF FC DOMAIN OF ANTIBODY

BINDING PROTEINS THAT TARGET aC1s, TfR, OR BOTH, AND COMPOSITIONS THEREOF

ANTI-SURVIVIN ANTIBODIES AND USES THEREOF

METHODS FOR TREATMENT OF MYELOPROLIFERATIVE NEOPLASMS

MONOCLONAL ANTIBODIES DIRECTED TO PHOSPHORYLATED PSD95 AND USES THEREOF

BK VIRUS NEUTRALIZING ANTIBODIES

ROR1/EGFR BI-SPECIFIC ANTIGEN BINDING MOLECULES

RECOMBINANT ANTIBODIES, KITS COMPRISING THE SAME, AND USES THEREOF IN DIAGNOSING AFRICAN SWINE FEVER VIRUS

PEPTIDE THAT SPECIFICALLY BINDS TO PPC REGION OF SARS-COV-2 SPIKE PROTEIN AND COMPOSITION FOR PREVENTING SARS-COV-2 INFECTION USING THE SAME

MODULATORS OF PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9)

MONOCLONAL ANTIBODY AGAINST TFPI AND USE THEREOF

USE of Antibody Mutation FOR Therapeutic Antibody Drug

ANTI-IL1RAP ANTIBODIES AND COMPOSITIONS

METHOD OF TREATING DISEASES OR CONDITIONS BY ADMINISTERING AN ANTI-INTERLEUKIN-11 RECEPTOR SUBUNIT ALPHA (IL-11RA) ANTIBODY

ANTI-IL 18BP ANTIBODIES

ANTI-CCR8 ANTIBODIES AND USES THEREOF

ANTI-MICA/B ANTIBODIES AND USES THEREOF

MULTIFUNCTIONAL RECOMBINANT ANTIBODY, PREPARATION METHOD AND USE THEREOF

Antibodies Directed Against T Cell Immunoglobulin and Mucin Protein 3 (TIM-3)

BISPECIFIC ANTIBODY CONTAINING ANTI-CLDN18.2 ANTIBODY, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF

NOVEL ANTI-GPRC5D ANTIBODIES, BISPECIFIC ANTIGEN BINDING MOLECULES THAT BIND GPRC5D AND CD3, AND USES THEREOF

ANTIBODIES THAT BIND INTERLEUKIN 13 AND METHODS OF USE

ANTI-FAMILY WITH SEQUENCE SIMILARITY 19, MEMBER A5 ANTIBODIES AND METHOD OF USE THEREOF

ANTI-MESOTHELIN ANTIBODIES

MODIFIED IMMUNOGLOBULINS FOR TARGETING AMYLOID DEPOSITS

ANTI-O2 ANTIBODIES AND USES THEREOF

MULTISPECIFIC ANTIBODIES TARGETING MULTIPLE EPITOPES ON THE HIV-1 ENVELOPE

ANTIBODIES SPECIFIC TO MUC18

CD38 MODULATING ANTIBODY AGENTS

C-KIT BINDING PROTEINS, CHIMERIC ANTIGEN RECEPTORS, AND USES THEREOF

IGM ANTIBODIES DEGRADING IGG

ANTIGEN BINDING PROTEINS

ANTI-TISSUE FACTOR ANTIBODIES, ANTIBODY-DRUG CONJUGATES, AND RELATED METHODS

ANTI-CEACAM5 ANTIBODIES AND USES THEREOF

MULTISPECIFIC POLYPEPTIDE CONSTRUCTS HAVING CONSTRAINED CD3 BINDING AND RELATED METHODS AND USES

BISPECIFIC ANTIBODY TARGETING EMR2 (CD312) AND THE T-CELL RECEPTOR TRBV19

PEPTIDE, ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF SPECIFICALLY BINDING TO ACE2 RECEPTOR, AND COMPOSITIONS FOR PREVENTING SARS-COV-2 CONTAINING THE SAME

CD39/CD73 BISPECIFIC ANTIGEN BINDING PROTEIN AND USE THEREOF

ANTI-TNF-LIKE LIGAND 1A (TL1A) ANTIBODIES

ANTIBODIES THAT BIND TO IL1RAP AND USES THEREOF

NEO-2/15 Variants and Uses Thereof for Preferentially Stimulating T-Regulatory Cells

ANTITUMOR IMMUNE CHECKPOINT REGULATOR ANTAGONISTS

PROTEASE CLEAVABLE RECOMBINANT BISPECIFIC ANTIBODIES AND COMPOSITIONS AND USES THEREOF

LY6G6D BINDING PROTEINS, NUCLEIC ACIDS ENCODING SUCH PROTEINS, AND METHODS FOR THE PREPARATION AND USE THEREOF

ANTI- SIGLEC-15 BINDING MOLECULES AND METHODS OF USE

NOVEL ANTI-LILRB4 ANTIBODIES AND USES THEREOF

New Interleukin-7 Immunoconjugates

MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING DYSTROPHINOPATHIES

ANTI-VISTA ANTIBODIES AND FRAGMENTS

ANTIBODIES AND ANTIBODY FRAGMENTS THAT BIND IGE

ANTIBODIES AND ANTIBODY FRAGMENTS THAT BIND IGE

ANTIBODIES AND ANTIBODY FRAGMENTS THAT BIND IGE

CORONAVIRUS-INHIBITING ANTIBODIES

AFFINITY MATURED ANTI-OX40 ANTIBODIES AND USE THEREOF

EGFR BINDING COMPLEX AND METHOD OF MAKING AND USING THEREOF

ANTI-HLA-G ANTIBODIES, COMPOSITIONS COMPRISING ANTI-HLA-G ANTIBODIES AND METHODS OF USING ANTI-HLA-G ANTIBODIES

COMPOSITIONS AND METHODS COMPRISING ANTIBODIES THAT BIND TO COVALENT PEPTIDE CONJUGATES

FcRn-Binding Polypeptides and Uses Thereof

MULTISPECIFIC BINDING AGENTS THAT TARGET B7H3 AND GD2 AND USES THEREOF

ANTI-BTN3A ANTIBODIES FOR USE IN METHODS OF TREATING GASTRO-INTESTINAL INFLAMMATORY DISORDERS

CD19-TARGETING CHIMERIC ANTIGEN RECEPTOR AND USE THEREOF

COMPOSITIONS AND METHODS FOR TARGETED DELIVERY OF THERAPEUTIC AGENTS

Preventative Agent or Therapeutic Agent for Amyotrophic Lateral Sclerosis, Parkinson's Disease, Huntington's Disease, Spinocerebellar Ataxia, Aging-Related Degenerative or Neurological Disease, Brain Aging, or Diseases Associated With Brain Aging

ANTI-FAMILY WITH SEQUENCE SIMILARITY 19, MEMBER A5 ANTIBODIES AND METHOD OF USE THEREOF

LRRC-15-BINDING PROTEIN CONSTRUCTS AND USES THEREOF

BINDING MOLECULES FOR BCMA AND CD3

T CELL BINDING PROTEINS

ANTIBODY MOLECULES THAT BIND PD-L1 AND CD137

ANTIBODY MOLECULES

ANTI-BDCA2 ANTIBODY AND USE THEREOF

ANTI-FCRN ANTIBODIES

ANTI-PD-L1 ANTIBODIES AND METHODS OF USE THEREOF

ANTI-HUMAN VISTA ANTIBODIES AND USE THEREOF

DUAL SPECIFIC ANTIBODIES

IL-23 ANTIBODY COMPOSITIONS AND METHODS OF USE

METHODS FOR DETECTING OR TREATING ATHEROSCLEROSIS

CANINIZED AND FELINIZED ANTIBODIES TO HUMAN NGF

CONFORMATION-SPECIFIC EPITOPES IN ALPHA-SYNUCLEIN, ANTIBODIES THERETO AND METHODS RELATED THEREOF

ANTI-AP2 ANTIBODIES AND ANTIGEN BINDING AGENTS TO TREAT METABOLIC DISORDERS

BISPECIFIC ANTIBODIES AND METHOD OF TREATING OCULAR DISEASE

METHODS FOR TREATING DIABETIC KIDNEY DISEASE AND GLOMERULAR DISEASE

COMPOUNDS USEFUL TO TREAT METABOLIC DISORDERS

ANTI-PD-L1 SINGLE-DOMAIN ANTIBODY AND DERIVATIVES AND USE THEREOF

TREATING CHEMORESISTANT CANCERS WITH NOTCH3 INHIBITORS

AAV DRUG FOR TREATING ANGIOGENESIS-RELATED FUNDUS DISEASES

VL ANTIGEN BINDING PROTEINS EXHIBITING DISTINCT BINDING CHARACTERISTICS

HUMAN ANTIBODIES AGAINST TISSUE FACTOR AND METHODS OF USE THEREOF

ANTIBODY FC VARIANTS

BINDING PROTEIN

ANTI CD40 ANTIBODY, ANTIGEN BINDING FRAGMENT AND MEDICAL USE THEREOF

THERAPEUTIC ANTIBODIES

Methods and Compositions Relating to GLP1R Variants

Methods of Treating IL1RAP Associated Cancers with Anti Human Interleukin-1 Receptor Accessory Protein (IL1 RAP) Antibodies

EPHA2-TARGETING ANTIBODIES AND THEIR APPLICATIONS IN CANCER TREATMENT

CANINIZED ANTIBODIES TO CANINE INTERLEUKIN-31 RECEPTOR ALPHA II

CANINIZED ANTIBODIES TO CANINE INTERLEUKIN-31 RECEPTOR ALPHA I

ANTIBODIES

ANTI-PD-L1 MONOCLONAL ANTIBODIES AND FUSION PROTEINS WITH INTERLEUKIN-15, INTERLEUKIN-15 RECEPTOR ALPHA, OR INTERLEUKIN-2

Anti-CTLA Antibody Compositions and Related Methods

ANTI-TCR ANTIBODY MOLECULES AND USES THEREOF

ANTIBODY CONSTRUCTS FOR DLL3 AND CD3

CD3 BINDING ANTIBODIES

CD3 TARGETING ANTIBODIES AND USES THEREOF

CLDN18.2-TARGETING ANTIBODY, BISPECIFIC ANTIBODY AND USE THEREOF

ANTIBODY AND USE THEREOF

CANINIZED ANTIBODIES TO HUMAN NGF

Novel Molecules for Therapy and Diagnosis

CANINE ANTIBODY LIBRARIES

BISPECIFIC ANTIBODY COMPRISING A HETERODIMER BASED ON MHC PROTEINS

BLOOD-BRAIN BARRIER TRANSLOCATING PEPTIDES AND RELATED MOLECULES AND METHODS OF USE THEREOF

COMBINATION THERAPY WITH ANTI-PVRIG ANTIBODIES FORMULATIONS, ANTI-TIGIT ANTIBODIES, AND ANTI-PD-1 ANTIBODIES

HUMANIZED CC CHEMOKINE RECEPTOR 4 (CCR4) ANTIBODIES AND METHODS OF USE THEREOF

METHOD AND MEANS FOR MODULATING B-CELL MEDIATED IMMUNE RESPONSES

DIAGNOSTICS FOR PORPHYROMONAS GINGIVALIS

FCRN/ANTIGEN-BINDING MOLECULES AND METHODS OF USE

ACTIVATABLE ANTIGEN-BINDING PROTEIN CONSTRUCTS AND USES OF THE SAME

MAGEB2 BINDING CONSTRUCTS

HUMANIZED HH1

TRANSFERRIN RECEPTOR-BINDING DOMAINS AND PROTEINS COMPRISING THE SAME

ANTIBODIES CAPABLE OF BINDING TO OX40, VARIANTS THEREOF AND USES THEREOF

ANTIBODIES CAPABLE OF BINDING TO OX40, VARIANTS THEREOF AND USES THEREOF

ANTI-CD137 ANTIBODIES FOR COMBINATION WITH ANTI-PD-1 ANTIBODIES

IMMUNOGLOBULIN PROTEINS THAT BIND TO NPR1 AGONISTS

Anti-IL18 Binding Protein Antibodies and Methods of Use Thereof

COMPOSITIONS AND METHODS RELATED TO IL2 RECEPTOR BINDING

BISPECIFIC CHECKPOINT INHIBITOR ANTIBODIES

KLRB1 BINDING AGENTS AND METHODS OF USE THEREOF

ANTIGEN BINDING PROTEINS TARGETING AN HLA-RESTRICTED PRAME PEPTIDE

MULTI-DOMAIN MOLECULES

PLANT-DERIVED THERAPEUTIC MONOCLONAL ANTIBODIES AND THEIR USE IN PREGNANT WOMEN

CTLA-4 Binding Molecule and Use Thereof

ANTIBODIES SPECIFIC TO DELTA 1 CHAIN OF T CELL RECEPTOR

ANTI-PVRIG ANTIBODIES AND METHODS OF USE

MULTIFUNCTIONAL MOLECULES THAT BIND TO T CELL RELATED CANCER CELLS AND USES THEREOF

ANTI-CLDN18.2 ANTIBODY, AND ANTIBODY-DRUG CONJUGATE AND USE THEREOF

ANTI IL-6 DOMAIN ANTIBODIES WITH FATTY ACID SUBSTITUENTS

IL-5 ANTIBODY, ANTIGEN BINDING FRAGMENT THEREOF, AND MEDICAL APPLICATION THEREFOR

ANTIGEN BINDING MOLECULE FORMATS

ANTI-FAM19A5 ANTIBODIES AND USES THEREOF

HEAVY CHAIN ONLY ANTIBODIES TO PDGF